In the glioblastoma group, the outcome was comparable to the entire group (parameters such as CNS WHO grade, treatment and IDH status were not applicable here); the imaging parameter pattern 1 did not retain its significance for PFS or OS (Table 2). The gene discussed is IDH2; the disease is glioblastoma.